A recent meta-analysis of VEGF-A expression in gastric cancer showed that VEGF-A overexpression was associated with poor overall survival (OS) (hazard ratio [HR] = 1.57; 95% confidence interval [CI], 1.30–1.84) and disease-free survival (DFS) (HR = 1.85; 95% CI, 1.39–2.32) [13]. This evidence concerns the gene VEGFA and gastric cancer.